| |
Pre
|
90 min
|
24 h
|
48 h
|
72 h
|
|---|
|
Placebo
|
|
CRP, mg/dL
|
|
Control
|
0.07 ± 0.04
|
0.07 ± 0.04
|
0.07 ± 0.03
|
0.06 ± 0.02
|
0.05 ± 0.02
|
|
Exercise
|
0.08 ± 0.02
|
0.11 ± 0.05
|
0.15 ± 0.05*
|
0.11 ± 0.05
|
0.10 ± 0.03
|
|
CK, U/L
|
|
Control
|
94 ± 10
|
98 ± 8
|
89 ± 8
|
87 ± 9
|
90 ± 11
|
|
Exercise
|
93 ± 8
|
126 ± 13
|
396 ± 72*, **
|
257 ± 48*, **
|
192 ± 32*
|
|
Herb
|
|
CRP, mg/dL
|
|
Control
|
0.13 ± 0.05
|
0.14 ± 0.05
|
0.11 ± 0.04
|
0.11 ± 0.04
|
0.11 ± 0.03
|
|
Exercise
|
0.10 ± 0.03
|
0.09 ± 0.03
|
0.15 ± 0.03*
|
0.10 ± 0.02
|
0.10 ± 0.02
|
|
CK, U/L
|
|
Control
|
110 ± 12
|
108 ± 9
|
119 ± 17
|
109 ± 11
|
113 ± 16
|
|
Exercise
|
106 ± 9
|
195 ± 51*
|
291 ± 35*, **
|
204 ± 26*, **
|
151 ± 20
|
|
TBARs, μM
|
|
Placebo
|
7.1 ± 1.1
|
8.1 ± 1.5
|
7.9 ± 1.0
|
6.5 ± 1.0
|
-
|
|
Herb
|
7.0 ± 1.0
|
6.6 ± 0.8
|
8.1 ± 0.9
|
5.7 ± 0.6
|
-
|
|
IL-6, pg/ml
|
|
Placebo
|
0.44 ± 0.1
|
0.69 ± 0.1*
|
0.32 ± 0.1
|
0.46 ± 0.1
|
-
|
|
Herb
|
0.50 ± 0.2
|
0.45 ± 0.1
|
0.23 ± 0.1*
|
0.29 ± 0.1
|
-
|
|
TNF-α, pg/ml
|
|
Placebo
|
0.45 ± 0.14
|
0.28 ± 0.06
|
0.30 ± 0.06
|
0.30 ± 0.06
|
-
|
|
Herb
|
0.44 ± 0.06
|
0.34 ± 0.06
|
0.38 ± 0.08
|
0.34 ± 0.06
|
-
|
- Values are means ± SEM. TBARs, IL-6, and TNF-α were measured only during the eccentric exercise session
-
CRP C-reactive protein, CK creatine kinase, TBARs thiobarbituric acid reactive substances, IL-6 interleukin-6, TNF-α tumor necrosis factor-α
- *P<0.05 vs. Pre in the same condition. **P<0.05 vs. Control or Placebo at the same time point
